CompletedNCT02136147
Medication Outcomes and Predictors in Children and Teens With ADHD
About this title
Read the official source —Observational studyAges 6–18Sweden
Understand this study
Who was this study for?
Listed age limits: 6 years to 18 years.
- Listed locations
- StockholmSee all locations and recruitment
Study information
Study start dateStarted: June 2015
- Recruitment status
- Completed
- Enrollment listed in the registry
- 632
- Sponsor
- Karolinska Institutet
- Sponsor type
- Unknown or unclear
- Study type
- Observational
- Intervention type
- Medication / drug
- Study phase
- Not clearly listed
- Locations
- Sweden
- Age range
- From 6 Years to 18 Years
- Official registry ID
- NCT02136147
- Official title
Show the full official title
Naturalistic Study of ADHD Medication and Predictors of Treatment Outcome
Get this study by email
Recruitment & locations
CompletedStockholm
Questions about this study
Who is behind this study?
The study sponsor is Karolinska Institutet.
Did this study involve medication?
Yes. The study involved medication, including methylphenidate medication, atomoxetine medication, lisdexamphetamine medication and guanfacine medication.
Who was this study for?
Listed age limits: 6 years to 18 years.
